Skip to main content

Avacopan in GPA - non-inferior to prednisone for induction remission - received FDA approval for treatment of severe ac

May 19, 2023 7:00 pm
Social Author Name
Dr. John Cush
Tweet Content
Avacopan in GPA - non-inferior to prednisone for induction remission - received FDA approval for treatment of severe active GPA in combo with standard therapy and steroids - should be used in newly diagnosed active or relapsing disease @rheumnow #RNL2023 https://t.co/My6M5MGBl1 https://t.co/0aPFUeE55Q
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×